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Enzootic nasal adenocarcinoma (ENA) is a contagious neoplasm of the secretory epithelial cells of the nasal mucosa
of sheep and goats. It is associated with the betaretrovirus, enzootic nasal tumor virus (ENTV), but a causative
relationship has yet to be demonstrated. In this study, 14-day-old lambs were experimentally infected via
nebulization with cell-free tumor filtrates derived from naturally occurring cases of ENA. At 12 weeks post-infection
(wpi), one of the five infected lambs developed clinical signs, including continuous nasal discharge and open
mouth breathing, and was euthanized. Necropsy revealed the presence of a large bilateral tumor occupying the
nasal cavity. At 45 wpi, when the study was terminated, none of the remaining infected sheep showed evidence of
tumors either by computed tomography or post-mortem examination. ENTV-1 proviral DNA was detected in the
nose, lung, spleen, liver and kidney of the animal with experimentally induced ENA, however there was no
evidence of viral protein expression in tissues other than the nose. Density gradient analysis of virus particles
purified from the experimentally induced nasal tumor revealed a peak reverse transcriptase (RT) activity at a
buoyant density of 1.22 g/mL which was higher than the 1.18 g/mL density of peak RT activity of virus purified
from naturally induced ENA. While the 1.22 g/mL fraction contained primarily immature unprocessed virus particles,
mature virus particles with a similar morphology to naturally occurring ENA could be identified by electron
microscopy. Full-length sequence analysis of the ENTV-1 genome from the experimentally induced tumor revealed
very few nucleotide changes relative to the original inoculum with only one conservative amino acid change.
Taken together, these results demonstrate that ENTV-1 is associated with transmissible ENA in sheep and that under
experimental conditions, lethal tumors are capable of developing in as little as 12 wpi demonstrating the acutely
oncogenic nature of this ovine betaretrovirus.Introduction
Enzootic nasal adenocarcinoma (ENA) is a neoplasm of
the secretory epithelial cells of the nose of sheep and
goats [1]. ENA tumors can arise unilaterally or bilaterally,
originating from the ethmoid turbinate and often expanding
to occlude the nasal cavity. No metastasis has been reported
in ENA cases, but disruption of the nasal septum structure
as well as erosion of the cribiform plate has been reported
[2,3]. Due to the cell type transformed and the space occu-
pying nature of the tumor, the clinical signs of ENA include
production of copious nasal exudate, open mouth breath-
ing, dyspnea and facial asymmetry [1]. A neoplasm of the
secretory epithelial cells of the distal lung of sheep, called* Correspondence: kwootton@uoguelph.ca
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reproduction in any medium, provided the orovine pulmonary adenocarcinoma (OPA), is known to be
caused by jaagsiekte sheep retrovirus (JSRV) [4] and a simi-
lar etiology is suspected for ENA [5,6]. ENA is associated
with the betaretrovirus, enzootic nasal tumor virus (ENTV),
which is genetically very similar to JSRV [7]. ENTV is
divided into two distinct sub species, one infecting sheep
(ENTV-1) [7] and the other infecting goats (ENTV-2) [8].
Studies involving ENTV are hindered by the fact that
there is no cell culture system for propagating the virus.
Although a causal relationship between ENTV-1 infection
and the development of ENA in sheep has not been proven,
reverse transcriptase activity, ENTV-1 specific nucleotide
fragments and antigens that cross react with antibodies
against JSRV proteins are consistently found in nasal ex-
udate as well as nasal tumor tissue [3,5,9,10]. ENA has
been shown to be infectious in goats through intrasinus ortd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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nasal exudates pooled from three ENA affected goats [11].
In 1953, Cohrs reported transmission of ENA in sheep
using cell and bacteria-free tumor filtrate [12], but more
recently, similar experiments attempting transmission of
ENA in sheep were unsuccessful (Dr James DeMartini,
personal communication).
In this study, we tested the hypothesis that ENA can
be induced in healthy l4-day-old lambs after exposure
to nebulized cell-free tumor homogenate derived from
sheep with ENA. We show that while the rate of tumor
induction was low, clinical signs could be detected as
early as 12 wpi. The clinical signs, histopathology, and
tissue distribution of ENTV-1 provirus in experimen-
tally and naturally infected animals were similar, thereby
validating the experimental infection method used in
this study and providing further support for the hypoth-
esis that ENTV-1 is the causative agent of ENA in sheep.
Materials and methods
Animals, inoculum, and sample collection
The Animal Care Committee at the University of Guelph
approved all animal use and related procedures. Five
lambs born to dams from a research flock at the University
of Guelph with no previous history of ENA were infected
at 14 days of age with two mL of ENA inoculum. Two
lambs were mock infected with vehicle alone and were
housed with the experimentally infected animals. All lambs
were examined by a veterinarian and were clinically healthy
prior to infection.
The ENA inoculum, which was comprised of cell-free
tumor homogenate, was prepared as follows. Equal amounts
of tumor tissue (~1 g/tumor) from ten different ENA
samples from North America (ENTV-1NA1-10; [3]) were
combined and homogenized using a Warring blender.
The homogenized tumor cell suspension was diluted in
phosphate buffered saline (PBS) (10% w/v) and clarified
at 18 000 × g for 40 min before concentration by ultra-
centrifugation in a SW31Ti rotor (Beckman Coulter
Canada) at 60 000 × g for 2 h at 4°C. The resulting pellet
was resuspended in 12 mL of PBS and passed through a
0.45 μm filter.
To ensure efficient delivery of the ENA inoculum to
the entire respiratory tract, nebulization was employed.
A mask possessing a rubber seal to optimize a tight fit
around the nose was fabricated and fitted with an inhaler
connector and a one way “T” valve. Conventional 6 mL
misty-Neb nebulizer cups (Wilder medical, Kitchener, ON,
Canada) were employed to deliver the inoculum. Nebuliza-
tion was performed using a PM14 compressor (Precision
Medical Inc., Northampton, PA, USA).
Peripheral blood mononuclear cells (PBMCs) were
collected from infected and control lambs prior to in-
oculation and every two wpi and stored at −80°C.Animals were euthanized after the onset of clinical
signs or, in the absence of clinical signs, at 45 wpi. At
necropsy, the nose was serially cut transversely at ~2 cm
intervals and samples of normal conchae and lesions were
collected. Tissue samples collected at necropsy included,
trachea, lung, submandibular lymph node, liver, spleen,
and kidney. These samples were divided in half and stored
at −80°C for subsequent isolation of nucleic acids and pro-
tein or fixed in 10% neutral buffered formalin for 24 h
prior to embedding in paraffin wax and sectioning.Computed tomography (CT)
Computed tomography of the head was performed using
a GE Bright Speed 16-slice helical CT scanner. The scan
parameters were 120 kvp, 200 mA, 1.25 mm slice thick-
ness, and 0.75 pitch. For the CT scan, lambs were anesthe-
tized using routine veterinary methods for this species.
Images were interpreted by a board certified veterinary
radiologist (HC).Histopathology and immunohistochemistry
Formalin-fixed tissues were trimmed, embedded in paraffin,
sectioned at 5 μm and processed to obtain haematoxylin-
eosin stained sections. The avidin-biotin-peroxidase com-
plex (ABC) method was used on paraffin-embedded tissue
sections for immunohistochemical demonstration of ENTV
envelope protein expression as described previously [3].
Neoplastic tissue was stained with antibodies to pankeratin
(Cell Signaling, clone C11), CK7 (DAKO, clone OVTL 12/30)
and vimentin (DAKO, clone V9).Heminested PCR (hnPCR)
Genomic DNA was extracted from PBMCs and homoge-
nized tissue samples using the Qiagen DNeasy blood and
tissue kit (Qiagen) according to the manufacturer’s in-
structions. An exogenous ENTV-1 specific hnPCR assay
was used to screen for integrated ENTV-1 provirus as
described previously [3]. Specificity of the PCR products
was confirmed by sequencing. Genomic DNA extracted
from the lung tissue of a healthy sheep served as a nega-
tive control.Buoyant density analysis
Approximately 3 g of tumor tissue was homogenized as
described above. Pelleted virus was resuspended in 1 mL
of PBS, placed on a linear 20 to 60% (wt/wt) discontinu-
ous sucrose gradient and centrifuged at 100 000 × g for
16 h at 4°C in a SW41 rotor (Beckman). 500 μL fractions
were collected and their density determined using a refract-
ometer (Fisher Scientific). Reverse transcriptase (RT) activity
of each fraction was determined using the EnzChek RTassay
kit (Invitrogen) according to manufacturer’s instructions.
Walsh et al. Veterinary Research 2013, 44:66 Page 3 of 13
http://www.veterinaryresearch.org/content/44/1/66Western blot analysis
Western blot analysis was conducted as described previ-
ously [13] using monoclonal antibodies specific for the en-
velope protein of ovine betaretroviruses (i.e. JSRV, ENTV
and enJSRV) [14] and capsid [15] (kindly provided by
Dr Hung Fan, University of California, Irvine) proteins.Electron microscopy
Buoyant density fractions containing the greatest RT activity
were combined, diluted to 30 mL with PBS and placed on a
5 mL 20% sucrose cushion. Virus was pelleted by ultracen-
trifugation at 18 000 × g for 2 h at 4°C and resuspended in
300 μL of HEPES buffer. Virus was then placed on a carbon
grid, negatively stained with uranyl acetate and examined
using a LEO 912ab transmission electron microscope at the
Electron Microscopy Unit, University of Guelph.Sequence analysis
Exogenous ENTV-1 specific primers [3] were used to amp-
lify three overlapping fragments, covering the full-length
ENTV-1 genome, from a genomic DNA extract of the
experimentally induced tumor. The PCR products were
sequenced directly and the full genome sequence desig-
nated, ENTV-1OVC, was analyzed using the MEGA5
software package.Nucleotide sequence accession number
The nucleotide sequence of ENTV-1OVC was deposited













Figure 1 Reverse transcriptase activity assay and immunoblot analysi
inoculum was quantified using a fluorogenic based assay (A) and compare
from a sheep skin fibroblast cell line. (B) Immunoblot analysis of cell lysate
cell lysate from a naturally occurring ENA tumor (lane 3) with envelope sur
molecular weight marker.Results
Tumor induction in a lamb after inoculation with
ENA homogenate
In this study, we tested the hypothesis that ENA could
be induced in 14-day-old lambs using a cell free prepar-
ation of tumor homogenate derived from naturally oc-
curring cases of ENA in sheep. ENTV-1 was detected in
the ENA inoculum by RT activity (Figure 1A) and by
immunoblot analysis with antibodies specific for ovine
betaretroviral envelope and capsid proteins (Figure 1B).
These results confirmed the presence of ENTV-1 anti-
gen and reverse transcriptase activity in the inoculum.
ENA inoculum was administered to five 14-day-old lambs
(two mL each) using a nebulizer. Clinical signs were ob-
served in one of the five infected lambs at 12 wpi and
included persistent nasal discharge, stridor, nostril flar-
ing, head shaking, sneezing and open mouth breathing
(Additional file 1). The lamb was euthanized and a post
mortem computed tomography (CT) scan was performed
(Figure 2A). This showed a bilateral soft tissue density
mass with poorly defined margins and a few pinpoint
areas of mineralization. The mass was associated with
adjacent sinusitis and fluid accumulation within the air
spaces and sinuses. The mass was causing destruction of
the bony cartilages of the nasal turbinates and occupied
approximately 50% of the overall nasal cavity, and ap-
proximately 95% of the nasal cavity at the site where it
was largest (Figure 2A).
Postmortem findings confirmed the results of the CT
scan. The nose of the lamb was sectioned rostral to cau-













s of ENA inoculum. The reverse transcriptase activity of the ENA
d to a mock inoculum comprised of concentrated filtered supernatant
from normal sheep nasal tissue (lane 1), ENA inoculum (lane 2) and
face subunit (Env SU) and capsid (CA) specific antibodies. M indicates
C D
B
Expt ENA Normal Nose
A
Figure 2 Computed tomography and gross pathological analysis of sheep experimentally infected with ENA inoculum. Three dimensional
reconstructed computed tomography scan of sheep experimentally infected with ENA inoculum with (A) and without (B) nasal tumors. Serial sections
of the nasal cavity of sheep experimentally infected with ENA inoculum with (C) and without (D) nasal tumors.
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had a heterogeneous texture and colour, ranging from
hard and pink to soft and red. It had several distinct
nodules protruding from the surface. The lungs were
palpated and inspected for tumors but no lesions were
detected. The experiment was terminated at 45 weeks
post-infection at which point the remaining four animals
were anaesthetized and subjected to CT scan followed by
euthanasia and necropsy. No signs of nasal tumor induc-
tion were observed in any of the four asymptomatic sheep
either by CT (Figure 2B) or necropsy (Figure 2D).
Histopathological identification of two tumor
morphologies in Expt ENA
Several different regions of the experimentally induced
ENA (Expt ENA) tumor were sectioned and separate
adenosquamous and fibropapillomatosis components were
found. The adenosquamous region (Figure 3A,B) had an
outer layer of normally differentiating stratified squamous
and keratinising epithelium which connected with under-
lying glandular epithelial cells that made up most of thiscomponent. The neoplastic glandular cells had twofold
variation in nuclear size and five mitoses in 10 high-
power fields.
The second region had a papillary appearance
(Figure 3C,D) with an outer layer of normally differenti-
ating, stratified squamous epithelium with long projec-
tions that extend into the underlying abundant fibrous
tissue that made up most of this mass.
Tumor tissue from a case of Natural ENA (Figure 3E,F)
had similar features to the adenosquamous region of
Expt ENA, but lacked features characteristic of the
fibropapillomatosis region.
Immunohistochemical detection of ENTV envelope protein
and CK7 in the adenosquamous region of Expt ENA
Immunohistochemical staining with a monoclonal antibody
specific for the ENTV Env protein of ovine betaretroviruses
[14] revealed a complete lack of staining of the normal
respiratory mucosa (Figure 4A and B) but intense apical
staining of epithelial cells comprising the Expt ENA
tumor (Figure 4C and D). Within the tumor, there was
Figure 3 Histopathology of nasal tumors from sheep experimentally infected with ENA inoculum and naturally acquired ENA.
Representative images of hematoxylin and eosin stained nasal tumors from sheep experimentally infected with ENA inoculum (A-D) and naturally
acquired ENA (E, F). Representative images showing the adenosquamous (A, B) and fibropapilloma (C, D) component of the experimentally
induced nasal tumor.
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cells displaying a glandular phenotype, but not of epithe-
lial cells with a stratified squamous differentiation pattern.
No specific staining of any of the stratified squamous epi-
thelial cells or of the stroma of the fibropapillomatosis
regions was observed. Staining of tumor tissue from a
case of Natural ENA showed a very similar pattern
(Figure 4E and F).
Staining with an anti-cytokeratin 7 antibody was
strongly positive for all epithelial cells of the normal
nasal mucosa including glands and luminal epithelial
cells (Figure 5A and B). All cells with a glandular pheno-
type in the adenosquamous portion of the tumor had
strong cytoplasmic staining (Figure 5C and D), but none
of the cells in the fibropapillomatosis region had posi-
tive staining (Figure 5E and F). Since CK7 and envelope
expression were observed in the adenosquamous region
of the tumor but were lacking in the faibropapillomatosis
region this suggests that the adenosquamous region is
derived from the tubuloglandular epithelial cells of the
nose but that the fibropapillomatosis region is not. The
fibropapillomatosis region is likely derived from stromalcell expansion induced to support the growth of the
envelope positive adenosquamous tumor region. Im-
munohistochemical staining for high molecular weight
cytokeratin was absent from both the adenosquamous
and the fibropapillomatosis regions of the tumor (data
not shown).
Tissue distribution of ENTV-1 proviral DNA
Genomic DNA was extracted from the nose, trachea,
lung, mandibular lymph node, spleen, liver and kidney
of experimentally infected sheep and analyzed for the
presence of ENTV-1 proviral DNA using ENTV-1 specific
hemi-nested PCR primers [3]. All samples from mock
infected sheep were negative for virus (data not shown).
ENTV-1 proviral DNA was detected in the nose of the
sheep with experimentally induced ENA in the first round
of PCR (Figure 6A). In a second round of hemi-nested
PCR, proviral DNA was detected in the lung, spleen,
kidney and liver, but not in the lymph node or the tra-
chea of the sheep with the experimentally induced ENA
(Figure 6B). Interestingly, when DNA extracted from
the PBMCs of the experimentally infected sheep that
Figure 4 Immunohistochemical staining for ENTV-1 envelope protein expression in nasal tumors from sheep experimentally infected
with ENA inoculum and naturally acquired ENA. Representative images showing a lack of envelope protein expression in normal sheep nasal
epithelium (A, B) but robust expression on the apical surface of all cells within the adenosquamous portion of the experimentally induced
(C, D) and naturally acquired (E, F) ENA.
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assay, ENTV-1 provirus could not be detected at any time,
including two weeks after infection and two weeks prior
to euthanasia (data not shown). For the experimentally
infected sheep that did not develop ENA, ENTV-1 pro-
virus was absent from all tissues examined (Figure 6C).
Tissues positive for ENTV-1 provirus were examined
for viral protein expression by western blot and immu-
nohistochemical staining using an Env-specific monoclo-
nal antibody. Using these methods, ENTV Env protein
could only be detected in the nasal tumor tissue of the
sheep with ENA (data not shown).
Ovine betaretroviral virions detected in Expt ENA
homogenate by buoyant density analysis and
electron microscopy
Virus purified from the ENA inoculum and the Expt
ENA tumor were subjected to buoyant density analysis
on a discontinuous 20 to 60% sucrose density gradient.
A total of 10 fractions of 500 μL were collected and ana-
lyzed for reverse transcriptase activity (Figure 7A), density(Figure 7A), and capsid protein content (Figure 7B). A
peak of RT activity was observed in the ENA inoculum in
fraction 6, which corresponded to a density of approxi-
mately 1.18 g/mL (Figure 7A). The adjacent fraction 7 had
a density of 1.22 g/mL and also contained RT activity. By
western blot, a 27 kDa protein corresponding to the
capsid protein was detected in both fractions 6 and 7
(Figure 7B). Capsid protein was also detected in fraction
5 and 8. The Expt ENA sample showed an increase in
RT activity in fraction 6 with a density of 1.18 g/mL;
however the majority of RT activity in this sample was
found in fraction 7, which corresponded to a density of
1.22 g/mL (Figure 7A). Immunoblot analysis of Expt
ENA fractions 6 to 8 revealed the presence of multiple
capsid protein products of approximately 85, 78, 62, 57,
52, 40 and 27 kDa (Figure 7B).
On electron micrographic analysis, the fractions from
the buoyant density gradient with the highest RT activity
(fraction 6 and 7) had virus particles of similar size and
morphology in both the ENA inoculum (Figure 7C, left)
and Expt ENA (Figure 7C, right) samples. Particles were
Figure 5 Immunohistochemical staining for cytokeratin 7 (CK7) in experimentally induced nasal tumors and normal nasal mucosa.
Representative images showing low molecular weight CK7 staining in normal sheep nasal mucosa (A, B) as well as in the adenosquamous
portion of the experimentally induced nasal tumor (C, D) and absence of staining in the fibropapilloma portion of the experimentally induced







































Figure 6 Tissue distribution of ENTV-1 provirus in sheep experimentally infected with ENA inoculum. PCR (A) and hemi-nested PCR
(B and C) amplification of exogenous ENTV-1 proviral DNA from genomic DNA extracted from various tissues of sheep experimentally
infected with ENA inoculum. Distribution of ENTV-1 provirus in an experimentally infected sheep that developed a nasal tumor (A and B) and
in a sheep that did not (C). Genomic DNA isolated from healthy sheep lung (−) and naturally acquired ENA (+) were used as a negative and
positive controls, respectively. M indicates molecular weight marker.
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Figure 7 Buoyant-density and transmission electron micrograph analysis of ENA tumor homogenate. (A) 20 to 80% (wt/wt) sucrose
gradient isopycnic centrifugation of the original ENA inoculum and a preparation of cell free tumor homogenate from the experimentally
induced nasal tumor. The RT activity (solid lines) and density (dashed line) of each of the ten fractions is shown. (B) Immunoblot analysis for
ENTV-1 capsid protein in fractions one through ten. ENA inoculum was loaded as a positive control for capsid (lane C). (C) Transmission electron
micrograph analysis of fractions six and seven of the ENA inoculum (left) and cell free tumor homogenate from the experimentally induced nasal
tumor (Expt ENA; right) showing virus particles with typical betaretrovirus morphology.
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centrically was a spherical electron dense core. The par-
ticle surface was rough in appearance with the smooth
membrane interrupted at even intervals by structured
projections with an apparent trimeric symmetry. There
was an abundance of cellular debris on the electron
micrograph. No other viral particles were seen.ENTV-1 sequences in the experimentally induced tumor
are derived from ENTV-1NA9
Overlapping fragments comprising the complete ENTV-1
provirus were amplified from the genomic DNA of Expt
ENA tumor tissue and the full-length genome, designated
ENTV-1OVC, sequenced. Tissues were taken from separ-
ate distinct areas of the nasal tumor and combined for
DNA extraction and subsequent amplification. PCR prod-
ucts were sequenced in both directions and as reported
previously [3], no variation or evidence of quasispecies
was detected. Phylogenetic analysis showed ENTV-1OVC
shared a node with ENTV-1NA9 and was thus most
closely related to ENTV-1NA9 (Figure 8A). The ClustalW
alignment of ENTV-1OVC differed at every nucleotide
position in which ENTV-1NA9 differed from the consen-
sus sequence of all ENTV-1 genome sequences available
on GenBank. Wherever ENTV-1NA9 and ENTV-1OVC
diverged from the consensus sequence, they shared 100%
nucleotide identity (data not shown). ENTV-1OVC differed
from ENTV-1NA9 at six nucleotide positions and these dif-
ferences were not found in any ovine betaretrovirus se-
quences, exogenous or endogenous, currently available on
GenBank. The six nucleotide differences were distributed
across the genome (Figure 8B) with one occurring in the
U5, three in the gag gene and two in the pol gene. None of
the substitutions were located in the four hypervariable
regions previously identified in the ENTV-1 genome [3].
All of the nucleotide substitutions represented transition
mutations. Only one of the nucleotide differences resulted
in a non-synonymous mutation, causing an alanine to
valine mutation at amino acid 335 of the gag gene.Discussion
Although ENA is known to be a transmissible tumor in
goats [10], studies on the transmissibility of ENA in sheep
are lacking. While a longstanding correlation between
ENTV-1 and ENA suggests that this ovine betaretrovirus
is the causative agent of the nasal tumor [5,7], Koch’s
postulates had not been fulfilled. A nasal tumor with
components identical to ENA was induced in an inocu-
lated lamb, thus we provide convincing evidence that
ENA is caused by ENTV-1. We used a cell-free ENA
tumor homogenate to induce nasal tumors in healthy lambs
and found ENTV-1 viral antigens, proviral DNA, and virus
particles in the resultant tumor in one of five lambs.The time to lethal tumor development in our experimen-
tal infection trial was surprisingly short. One of five inocu-
lated animals developed clinical signs of ENA at 12 wpi.
Normally the estimated time for the development of natur-
ally acquired ENA ranges from one to three years or more.
Moreover, in a similar study conducted in goats, the tumor
latency was between 12 to 18 months [10].
Nebulization was chosen as the method for virus admin-
istration to efficiently distribute the inoculum throughout
the upper and lower respiratory tract. ENTV-1 proviral
DNA was detected in the nose, lung, spleen, liver and
kidney of the animal with experimentally induced ENA
suggesting a disseminated distribution. Although ENTV-1
provirus was detected in regions of the respiratory tract
other than the nose, this did not correlate with viral pro-
tein expression. Our inability to detect protein expression
in any of the tissues that were PCR positive for the virus,
other than the nose, suggests that either infection of these
tissues is non-productive or that infection events in these
tissues are so rare that only the use of extremely sensitive
methods such as hnPCR are able to detect them. It is
possible that the presence of proviral DNA in the spleen,
kidney and liver could be due to the migration of virus
infected macrophages or dendritic cells to these tissues
[16]. At no point during the infection trial was ENTV-1
proviral DNA detected in PBMCs. Ortin et al. were also
unable to detect ENTV-1 in the PBMCs of ENA affected
animals [8]. In contrast, JSRV is widely distributed both in
T and B lymphocytes and mononuclear phagocytes of
OPA affected animals [16,17]. Pseudotyping and receptor
binding experiments have shown that ENTV-1 and JSRV
envelope proteins both bind to and utilize the same recep-
tor, hyaluronidase 2 (Hyal2), for entry [18-21], but the
requirements for entry of these viruses have not been
evaluated in the context of the native virion. The entry
requirements for ENTV-1 and JSRV envelope pseudotyped
MLV particles differ slightly as ENTV-1 envelope requires
a lower pH than JSRV envelope to mediate entry in this
context [22]. It is possible that ENTV-1 requires an add-
itional cofactor for entry that JSRV does not and that this
cofactor is lacking in immune cells.
The tissue distribution pattern of ENTV-1 in the experi-
mentally infected sheep with ENA was similar to that
reported for naturally acquired ENA [8]. This demon-
strates that the infection method used in this study, while
likely more efficient, closely recapitulates what is seen
during natural transmission of the virus.
Tumor latency was much shorter in our experimen-
tally infected sheep than has been reported in natural
cases. This is likely a consequence of the amount of
virus in the inoculum and the young age at which the
lambs were infected, as a similar reduction in incubation
period was observed for newborn lambs experimentally

















































Figure 8 Phylogenetic analysis of ENTV-1OVC. (A) Phylogenetic relationship analysis of the full-length ENTV-1 genome sequence from the
experimentally induced nasal tumor (ENTV-1OVC) and all other full-length ENTV-1 genome sequences available on GenBank as well as genome
sequences from the genetically related ENTV-2 and JSRV. Accession numbers are shown in brackets. The percentage of replicate trees in which
the associated taxa clustered together in the bootstrap test (1000 replicates) is shown next to the branches. Phylogenetic analyses were
conducted using MEGA5 and all positions containing gaps and missing data were eliminated from the dataset. (B) A schematic showing the
location of nucleotide differences between ENTV-1OVC and the closely related ENTV-1NA9. Small arrows indicated nucleotide changes and large
arrows demarcate regions of variability previously identified.
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genomes into the nucleus where they integrate in order
to complete their replication cycle [24]. Fourteen day old
lambs were used in this study since cells in the respira-
tory tract would be expected to have a higher rate of cell
division than adult sheep thereby maximizing infection
efficiency. Additionally, the expression level of ovine
hyaluronidase 2 (Hyal2), the receptor for ENTV-1, ishigh in the fetus and then markedly declines in the
neonate [25].
The disease incidence was relatively low in our experi-
mental infection trial as only one of five infected animals
developed a nasal tumor and for the remaining four
animals, ENTV-1 provirus was undetectable by hnPCR.
Since our analysis confirmed the presence of ENTV-1
antigens, RT enzymatic activity, and intact virions in
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ENTV-1 proviral DNA in the four asymptomatic sheep
was due to a lack of infectious virions in the inoculum.
Possible explanations for the low tumor incidence in-
clude immune-mediated clearance of virus infected cells
and differences in genetic susceptibility to the virus.
Indeed, allelic and expression variability of restriction
factors and infection co-factors have been shown to in-
fluence the replicative fitness of ovine retroviruses [26-30].
As well, certain endogenous ovine betaretrovirus elements
restrict JSRV release [31] and have been shown to have
variable expression in respiratory tissues [32]. Whether
these endogenous elements have similar inhibitory effects
on ENTV-1 is currently unknown.
Currently, the immunological response to ENTV-1 in-
fection is poorly understood. ENA affected animals do
not appear to develop circulating antibodies towards
ENTV-1 [33]. This has been attributed to the immune
tolerance induced by expression of endogenous ovine
betaretrovirus transcripts in the thymus and peripheral
immune organs during ontogeny [34]. Similar studies
pertaining to JSRV and OPA have had limited success in
detecting a humoral immune response [33]. In sheep ex-
perimentally co-infected with JSRV and maedi-visna virus,
CD3(+) T cell and JSRV specific antibody responses were
detected and these correlated with the spontaneous re-
gression of JSRV-induced lung tumors [35]. A cell-
mediated response to ENTV-1 infection has yet to be
demonstrated and we did not see evidence of nasal in-
flammation or tumor related leukocytes in our study. It
is possible that the apparent lack of virus specific im-
mune response in ENA affected sheep contributes to
tumorigenesis in these animals while sheep that are able
to mount a robust immune response against ENTV-1
are capable of clearing virus infected cells before the
onset of tumorigenesis.
There was no evidence of quasispecies in the proviral
sequence extracted from the Expt ENA tumor (ENTV-
1OVC), even though several different areas of the tumor
were sampled and PCR products sequenced directly. We
previously demonstrated that ENTV-1 genome sequences
amplified from North American ENA samples are sur-
prisingly stable [3]. Since the ENA inoculum used in the
experimental infection was generated from a combin-
ation of ten different North American ENA tumor sam-
ples, we were interested to determine which genome
sequences would predominate in Expt ENA and the ex-
tent of genetic variation. The lack of variation in the
ENTV-1OVC sequence suggests that the tumor likely
originated from a single integration event. Phylogenetic
analysis shows that ENTV-1OVC is most closely related
to ENTV-1NA9 and inspection of the ClustalW alignment
shows that ENTV-1OVC differs from ENTV-1NA9 at
only six nucleotides positions. Recombination was ruledout as a factor for introducing these nucleotide changes
because the nucleotide differences seen in ENTV-1OVC
relative to ENTV-1NA9 are not shared by any of the other
ten sequences represented in the virus inoculum. All six
of the nucleotide changes represent transition mutations,
which most likely occurred due to base mispairing during
reverse transcription of the genome. It is well documented
that retroviral reverse transcriptases have low fidelity
[36,37], thus it is likely that the RT of ENTV-1 is simi-
larly error prone. Alternatively, the nucleotide differences
observed in ENTV-1OVC existed previously in the ENTV-
1NA9 tumor and this area of the tumor was not sampled
during sequencing. Only one of the ENTV-1OVC nu-
cleotide substitutions corresponded to a nonsynonymous
change in the amino acid sequence at residue 335 in the
gag polyprotein. It is unlikely that this mutation would
affect the structure or function of the resulting protein
since the physiochemical properties of valine and alanine
are conserved; therefore, it is not likely to confer any
advantage in terms of pathogenesis or viral replicative
fitness.
Buoyant density analysis of the ENA inoculum fractions
showed only one band in the capsid immunoblot at
27 kDa, representing fully processed capsid. Conversely,
buoyant density analysis of Expt ENA showed multiple
bands on the capsid immunoblot, the size of which cor-
respond well with the molecular weight of the various
forms expected of unprocessed gag and gag-pro polyprotein
as well as partially processed gag products that contain
the capsid subunit [38]. Therefore, it appears that ma-
ture as well as immature virions were liberated from the
Expt ENA tumor whereas only mature virions were found
in the ENA inoculum. The peak RT activity of Expt ENA
occurred at a density of 1.22 g/mL whereas the RT activity
of ENA inoculum peaked at 1.18 g/mL, the buoyant dens-
ity expected for a retrovirus. Studies of closely related
oncoretroviruses have noted that naked viral cores have a
buoyant density of approximately 1.22 g/mL, which is
distinct from the buoyant density of enveloped virions
(1.15 to 1.18 g/mL) [39]. The immature nature of the vi-
rions and the increased buoyant density (1.22 versus
1.18 g/mL) indicate that although a proportion of the
Expt ENA virions were enveloped and processed, the
majority of virus in the tumor was comprised of naked
immature cores. It is possible that the mechanical forces
of homogenization sheared cells causing the release of
assembled but immature virus particles lacking an enve-
lope membrane. This phenomenon was not observed in
the Natural ENA because the fast growth of Expt ENA
and relative disorganized structure likely impaired vir-
ion release and caused an accumulation of unenveloped
virion cores in the cytoplasm of tumor cells. Electron
microscopic analysis supports this conclusion as mature
enveloped virions were clearly visible in the ENA inoculum,
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ENA tumor sample.
Taken together, the fact that the experimentally infected
sheep that developed ENA was inoculated with filterable
homogenate from ENTV-1 antigen and genome sequence
positive tumors strongly suggests that the nasal tumor
observed in this animal was caused by ENTV-1, thereby
further implicating ENTV-1 as the etiologic agent of
transmissible nasal tumors in sheep.
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